regorafenib
bayer
[]
very exciting to hear presentation at asco meeting in san francisco of agitg integrate study which showed improved survival with regorafenib in advanced gastric cancer. with patients and industry, we are finally starting to shift the bar in this disease #agitg #ascogi23
Cancer physician, GI medical oncologist, Professor of Cancer Research at School of Public health at Monash Uni, slow cyclist, professional student of the  sax